EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Optimized UPLC-MS/MS Method for the Simultaneous Quantification of Pazopanib and GSK-1268997 and Its Application to Drug-Drug Interaction Studies

Lu Cao, Peiqi Wang, Ruibin Li, Haoxin Fu, Jun Wu, Hailun Xia, Saili Xie, Congcong Zeng

Drug Design, Development and Therapy · 2026-04 · Volume 20 · 1-15

DOI: 10.2147/dddt.s589066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-04. Verfasst von Lu Cao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China. Hauptthemen laut MEDLINE: Sulfonamides, Pyrimidines. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfonamidesPyrimidinesIndazolesTandem Mass SpectrometryDrug InteractionsAnimalsRatsHumansMicrosomes, LiverChromatography, High Pressure LiquidMaleRats, Sprague-DawleyNicardipine

Stichwörter der Autor:innen

GSK-1268997UPLC-MS/MSnicardipinepazopanib

Substanzen

pazopanibSulfonamidesPyrimidinesIndazolesNicardipine

Autor:innen und Institutionen

  • Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
  • Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
  • Healthcare Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
  • Department of Traditional Chinese Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.

Zitieren

APA

Cao, L., Wang, P., Li, R., Fu, H., Wu, J., Xia, H., Xie, S., & Zeng, C. (2026). Optimized UPLC-MS/MS Method for the Simultaneous Quantification of Pazopanib and GSK-1268997 and Its Application to Drug-Drug Interaction Studies. Drug Design, Development and Therapy, Volume 20, 1-15. https://doi.org/10.2147/dddt.s589066

Vancouver

Cao L, Wang P, Li R, Fu H, Wu J, Xia H, et al. Optimized UPLC-MS/MS Method for the Simultaneous Quantification of Pazopanib and GSK-1268997 and Its Application to Drug-Drug Interaction Studies. Drug Design, Development and Therapy. 2026;Volume 20:1-15. doi:10.2147/dddt.s589066

BibTeX
@article{Cao2026,
  author = {Cao, Lu and Wang, Peiqi and Li, Ruibin and Fu, Haoxin and Wu, Jun and Xia, Hailun and Xie, Saili and Zeng, Congcong},
  title = {Optimized UPLC-MS/MS Method for the Simultaneous Quantification of Pazopanib and GSK-1268997 and Its Application to Drug-Drug Interaction Studies},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--15},
  doi = {10.2147/dddt.s589066}
}
Kostenlos starten →